MedPath

Administration of Ketamine to Prevent the Post-operative Pain

Phase 3
Completed
Conditions
Postoperative Pain
Breast Cancer
Registration Number
NCT00210210
Lead Sponsor
Institut Bergonié
Brief Summary

The surgery of breast cancer is responsible for post-operative pain, needing in about 30% some morphine consumption; like that, the association of ketamine with general anaesthesia may decrease morphine's use and so its adverse effects. The purpose is to evaluate the analgesic effect of a receptor NMDA's antagonist ( ketamine)

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
230
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Morphine consumption (first 48 post-operative hours)
Secondary Outcome Measures
NameTimeMethod
Visual analog rating scale during the first 48 post-operative hours: at 15mn,1H,2H,12H, 24H,36H,48H

Trial Locations

Locations (1)

Institut Bergonié - Centre Régional de Luttre Contre le Cancer de Bordeaux et du Sud Ouest

🇫🇷

Bordeaux, France

© Copyright 2025. All Rights Reserved by MedPath